As a pioneer in antibody-drug conjugates (ADCs), Seagen led the way in novel cancer therapeutics for more than 25 years. They were committed to discovering safe and effective solutions to challenging clinical needs. Their research efforts were dedicated to advancing a pipeline of innovative therapies for solid tumors and blood-related cancers. Seagen was acquired by Pfizer.

I worked with Seagen to evolve their corporate brand as their company grew and their products moved through the development pipeline. When the company changed their name from Seattle Genetics to Seagen, I refined the company logo and developed the core brand elements that were in use up to the acquisition. I provided a wide range of services that include external, internal, and investor communications as well as special events. The projects featured below represent a small sampling of the work I produced for this inspirational company.

Deliverables: